ORIC-944, a PRC2 inhibitor with best-in-class properties, restores luminal features and restricts adaptation in prostate cancer models, conferring synergy with AR pathway inhibitors ORIC-944 is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback